Moderna reports fiscal Q1 2026 results: revenue $389.0M, up 260% from a year earlier

Moderna filed a Form 8-K with the SEC on May 1, 2026, 6:32 AM ET, reporting an event dated May 1, 2026. It covers Item 2.02 (Results of Operations and Financial Condition); Item 9.01 (Financial Statements and Exhibits). The results cover fiscal Q1 2026 (quarter ended Mar 31, 2026); figures below are from the company's XBRL financial data filed with the SEC.

• Revenue: $389.0M (+260.2% from $108.0M a year earlier)
• Operating income: −$1.39B (vs −$1.05B a year earlier)
• Net income: −$1.34B (vs −$971.0M a year earlier)
• Diluted EPS: $-3.40 (vs $-2.52 a year earlier)
• Form 8-K accepted by EDGAR May 1, 2026, 6:32 AM ET
• Accession number 0001682852-26-000057

SEC filing 8-K · accession 0001682852-26-000057 · sec.gov ↗